On Omicron, Early Studies Are In And There Is "Cautious Optimism"

The earliest studies on omicron are in and the glimpse they're providing is cautiously optimistic: while vaccines like the one made by Pfizer Inc. and BioNTech SE may be less powerful against the new...

from NDTV News - Topstories https://ift.tt/3pJWSdH
https://ift.tt/eA8V8J